http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007072461-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fdebbba538beda282f70b33df9cfd5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edf4f85415030c718b0ea015457725c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2c7ba1c148b7079b4dd70b68b60988b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_747b3b1e358e8f3ab7fdbdff5a45cb06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f218ced6ba06e24bfaa38739487aa2d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
| filingDate | 2006-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f04fbfdb08c389e8fa90582e59e3db58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d966ad9bfe9a4dcfd3313a6411d48dfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3087088f1c8d00b3863ddb28dda00dc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_275cd798f752c2fdb2146ab36f46d8b2 |
| publicationDate | 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007072461-A2 |
| titleOfInvention | Modified proteins comprising a bioactive peptide/protein linked to a sequence of aminoacids containing a human carbohydrate binding module (cbm), and development of a system for the administration of therapeutically active proteins and respective utilizations for biomedical purposes |
| abstract | It has been developed a strategy to simultaneously improve the properties of starch-based biomaterials for biomedical applications and the efficiency of therapeutical proteins. This new strategy which is revealed in this invention consists of the fusion of a carbohydrate binding module (CBM) with bioactive peptides. The human CBM used in this work has starch affinity (SBM). This SBM was identified as a module of a laforin enzyme, a phosphatase, which has the function to attribute glycogen affinity. As has been demonstrated the SBM does also have starch affinity. This is a low cost polysaccharide available in large quantities and with different properties which has increasingly raised interest for the development of biomedical applications. The biocompatibility, versatility and biodegradability are relevant starch characteristics for the development of applications as the controlled release of drugs and tissue engineering. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498539-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022043991-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2508532-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2261231-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101885753-A |
| priorityDate | 2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.